Next Generation Risk Assessment (NGRA): Emerging Best Practice & Opportunities for Regulatory Use

When:  Jun 17, 2026 from 11:00 AM to 01:00 PM (ET)

A RASS Risk Assessment Syllabus Webinar

Registration is required for this free webinar

Hosted by the SOT Risk Assessment Specialty Section

This will be the seventh webinar in the Risk Assessment Syllabus series, which began in 2021. This webinar will bring together many of the concepts covered in prior topics to show how new approach methodologies (NAMs) can transform the Human Health Risk Assessment (covered on June 9, 2021) to advance more predictive, efficient, and human-relevant risk evaluations. Dr. Gavin Maxwell will present the next-generation risk assessment framework, its emergence as an industry best practice, and its potential applications in regulatory settings. Additional perspectives will be provided by three panelists who will cover Regulatory Perspective on Applying NAMs at the US EPA by Anna Lowit (US EPA); NAMs and Underlying Molecular Mechanisms by Ivan Rusyn (Texas A&M University); and NAMs and Applications at NIH/NIEHS by Nicole Kleinstreuer (NIH). As usual in this series, a Q&A discussion will follow the presentations, which will be led by our moderator, Dr. Laurie Haws (ToxStrategies).

Speaker

Gavin Maxwell, PhD, Head of Regulatory Science Strategy and Advocacy, Unilever

Panelists

Nicole Kleinstreuer, PhD, Deputy Director for Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health

Anna Lowit, PhD, Senior Science Advisor, US Environmental Protection Agency

Ivan Rusyn, PhD, Professor, Texas A&M University

Moderator

Laurie Haws, PhD, Cofounder and Managing Principal Scientist, ToxStrategies

Location